Agilent 1200 LC/G6410A Pharma Analysis Application Note

This application note describes a method for analyzing pharmaceuticals in water using solid-phase extraction (SPE) and liquid chromatography/tandem mass spectrometry (LC/MS/MS) in both positive and negative ion modes. Good linearity was observed for analytes from 1 pg to 1 ng on column. Repeatability from six injections of analytes at 5 pg on column showed RSDs below 15%, for all target compounds except for fluoxetine at 23%.


Agilent 1200 LC/G6410A Pharma Analysis Application Note - cover page
Brand
Agilent
Category
Other
Document type
Application Note
Language
English
Pages
12
File format
PDF
File size
325 KB
Published
02 July, 2012
Updated
01 October, 2023
MD5 checksum
A5D8929C6F240745821B2D145B7692F3

About this manual

This document details an analytical method for detecting trace levels of pharmaceuticals in water samples. The procedure utilizes Solid Phase Extraction (SPE) with Oasis HLB cartridges followed by analysis via Agilent 1200 LC coupled with a G6410A Mass Spectrometer. The method covers 19 compounds in positive ion mode and 11 in negative ion mode, achieving detection at low picogram levels without derivatization.

What's inside

  • Introduction
  • Instrumentation
  • Sample Preparation Procedure
  • Positive Ion Mode Parameters
  • Negative Ion Mode Parameters
  • MRM Method Parameters
  • Results and Discussion
  • Linearity Results
  • Repeatability Results

Specifications

ColumnZORBAX Extend-C-18, RRHT, 2.1 mm x 100 mm, 1.8 µm
Column temperature (Negative)60°C
Flow rate0.3 mL/min
Injection volume1.0 µL
Mass range (Positive)125 to 800 amu
Mass range (Negative)120-800 amu
Scan time300 ms
Capillary voltage3500 V
Drying gas flow9 L/min

Frequently asked questions

How many pharmaceuticals are analyzed in positive ion mode?

Nineteen pharmaceuticals are analyzed in positive ion mode.

What is the detection limit for the analytes?

Good linearity was observed for analytes from 1 pg to 1 ng on column.

What is the repeatability (RSD) for most compounds?

Repeatability showed RSDs below 15% for all target compounds except fluoxetine.

Download PDF (325 KB)

More Agilent Manuals


View all Agilent manuals →